Spero Therapeutics CEO to present at H.C. Wainwright global healthcare conference
SPRO•Conference presentation and meetings
Spero Therapeutics will present at the H.C. Wainwright 28th Annual Global Investment Conference in New York on Sept. 15, 2026.
Management plans one-on-one meetings during the conference, scheduled for Sept. 14-16, 2026.
